Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1111/JEP.13658 | ||||
| Año | 2022 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Rationale, Aims and Objectives In the context of a pandemic, the rapid development of clinical practice guidelines (CPGs) is critical. The guideline development process includes prioritization of the guideline topic, questions and health outcomes. This case study describes the application of a new methodology to prioritize questions and rate the importance of health outcomes for a COVID-19 dental guideline. Methods Panel members rated the topic and the questions' overall importance, using a 9-point scale (1 = least important; 9 = most important). In addition, they rated six criteria if multiple questions received the same overall importance rating: common in practice, uncertainty in practice, variation in practice, new evidence available, cost consequences, not previously addressed. Panellists also rated the importance of each outcome, defined with health outcome descriptors, using a 9-point scale and the utility of health outcomes on a visual analogue scale. The correlation between each criterion and overall question importance was tested by Spearman correlation coefficient. Results Of seven topics, four were rated as high priority and three were rated as important, but not of high priority. Thirty-six percent of the questions (18/50) were rated as high priority to address in the guideline and 64% (32/50) were rated as an important question but not of high priority. Of the 11 outcomes, 72.7% were rated as critical for decision making. The mean utility rating was 0.57 (SD 0.32), with a minimum mean rating of 0.16 and a maximum of 0.76 (SD 0.23). Conclusion This case study demonstrated that this approach provides a rigorous and transparent methodology to conduct the prioritizations of guideline topics, questions and health outcomes.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | ZAROR-SANCHEZ, CARLOS ELIAS | Hombre |
Universidad de La Frontera - Chile
|
| 2 | Deana, Naira Figueiredo | Mujer |
Universidad de La Frontera - Chile
|
| 3 | ESPINOZA-ESPINOZA, GERARDO | Hombre |
Universidad de La Frontera - Chile
|
| 4 | ARAVENA-RIVAS, YANELA | - |
Universidad de La Frontera - Chile
|
| 5 | MUÑOZ-MILLÁN, PATRICIA | Mujer |
Universidad de La Frontera - Chile
|
| 6 | PINEDA-TOLEDO, PATRICIA | Mujer |
Universidad de La Frontera - Chile
|
| 7 | Burdiles, Pamela | Mujer |
Ministerio de Salud - Chile
Universidad Nacional Andrés Bello - Chile Ministerio de Salud de Chile - Chile |
| 8 | Nahuelhual, Paula | Mujer |
Ministerio de Salud - Chile
Universidad del Desarrollo - Chile Ministerio de Salud de Chile - Chile |
| 9 | Canelo-Aybar, Carlos | Hombre |
IIB St Pau - España
CIBER Epidemiol & Salud Publ CIBERESP - España Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau) - España CIBER Epidemiología Y Salud Pública - España Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública - España Institut de Recerca Sant Pau (IR SANT PAU) - España |
| 10 | ALONSO-COELLO, PABLO | Hombre |
IIB St Pau - España
CIBER Epidemiol & Salud Publ CIBERESP - España Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau) - España CIBER Epidemiología Y Salud Pública - España Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública - España Institut de Recerca Sant Pau (IR SANT PAU) - España |
| Fuente |
|---|
| Agencia Nacional de Investigación y Desarrollo |
| Agencia Nacional de Investigacion y Desarrollo, Chile |
| Agradecimiento |
|---|
| Agencia Nacional de Investigacion y Desarrollo, Chile, Grant/Award Number: COVID0700 |
| We would like to acknowledge Ingrid Obrecht for her help in the English editing process of this manuscript. Financial support for this study was provided entirely by a grant from Agencia Nacional de Investigación y Desarrollo (ANID), Chile (COVID0700). The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report. |